imatinib mesylate has been researched along with Peripheral Nerve Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleinschmidt-Demasters, BK; Lillehei, KO; Seinfeld, J; Tayal, S | 1 |
| Bertucci, F; Dubreuil, P; Gonçalves, A; Monges, G; Viens, P | 1 |
2 other study(ies) available for imatinib mesylate and Peripheral Nerve Neoplasms
| Article | Year |
|---|---|
Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status.
Topics: Adult; Base Pair Mismatch; Benzamides; Brachial Plexus; Brachial Plexus Neuropathies; Chemotherapy, Adjuvant; Combined Modality Therapy; DNA Mutational Analysis; Exons; Female; Fibromatosis, Aggressive; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Peripheral Nervous System Neoplasms; Piperazines; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines; Reoperation | 2006 |
Desmoid-type fibromatosis.
Topics: Antineoplastic Agents; Benzamides; Brachial Plexus; Drug Resistance; Fibromatosis, Aggressive; Humans; Imatinib Mesylate; Peripheral Nervous System Neoplasms; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Stem Cell Factor | 2007 |